These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Characterization of proteinase K-resistant N- and C-terminally truncated PrP in Nor98 atypical scrapie. Klingeborn M; Wik L; Simonsson M; Renström LHM; Ottinger T; Linné T J Gen Virol; 2006 Jun; 87(Pt 6):1751-1760. PubMed ID: 16690942 [TBL] [Abstract][Full Text] [Related]
26. Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. Piccardo P; Dlouhy SR; Lievens PM; Young K; Bird TD; Nochlin D; Dickson DW; Vinters HV; Zimmerman TR; Mackenzie IR; Kish SJ; Ang LC; De Carli C; Pocchiari M; Brown P; Gibbs CJ; Gajdusek DC; Bugiani O; Ironside J; Tagliavini F; Ghetti B J Neuropathol Exp Neurol; 1998 Oct; 57(10):979-88. PubMed ID: 9786248 [TBL] [Abstract][Full Text] [Related]
27. Gerstmann-Sträussler-Scheinker: a new phenotype with 'curly' PrP deposits. Colucci M; Moleres FJ; Xie ZL; Ray-Chaudhury A; Gutti S; Butefisch CM; Cervenakova L; Wang W; Goldfarb LG; Kong Q; Ghetti B; Chen SG; Gambetti P J Neuropathol Exp Neurol; 2006 Jul; 65(7):642-51. PubMed ID: 16825951 [TBL] [Abstract][Full Text] [Related]
28. Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. Tagliavini F; Prelli F; Ghiso J; Bugiani O; Serban D; Prusiner SB; Farlow MR; Ghetti B; Frangione B EMBO J; 1991 Mar; 10(3):513-9. PubMed ID: 1672107 [TBL] [Abstract][Full Text] [Related]
29. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions. Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825 [TBL] [Abstract][Full Text] [Related]
30. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation. Tunnell E; Wollman R; Mallik S; Cortes CJ; Dearmond SJ; Mastrianni JA Neurology; 2008 Oct; 71(18):1431-8. PubMed ID: 18955686 [TBL] [Abstract][Full Text] [Related]
31. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues. Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541 [TBL] [Abstract][Full Text] [Related]
32. Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS. Asante EA; Grimshaw A; Smidak M; Jakubcova T; Tomlinson A; Jeelani A; Hamdan S; Powell C; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Collinge J PLoS Pathog; 2015 Jul; 11(7):e1004953. PubMed ID: 26135918 [TBL] [Abstract][Full Text] [Related]
33. In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrP Wang Z; Yuan J; Shen P; Abskharon R; Lang Y; Dang J; Adornato A; Xu L; Chen J; Feng J; Moudjou M; Kitamoto T; Lee HG; Kim YS; Langeveld J; Appleby B; Ma J; Kong Q; Petersen RB; Zou WQ; Cui L Mol Neurobiol; 2019 Aug; 56(8):5456-5469. PubMed ID: 30612334 [TBL] [Abstract][Full Text] [Related]
34. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Wadsworth JD; Joiner S; Linehan JM; Cooper S; Powell C; Mallinson G; Buckell J; Gowland I; Asante EA; Budka H; Brandner S; Collinge J Brain; 2006 Jun; 129(Pt 6):1557-69. PubMed ID: 16597650 [TBL] [Abstract][Full Text] [Related]
35. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Zou WQ; Puoti G; Xiao X; Yuan J; Qing L; Cali I; Shimoji M; Langeveld JP; Castellani R; Notari S; Crain B; Schmidt RE; Geschwind M; Dearmond SJ; Cairns NJ; Dickson D; Honig L; Torres JM; Mastrianni J; Capellari S; Giaccone G; Belay ED; Schonberger LB; Cohen M; Perry G; Kong Q; Parchi P; Tagliavini F; Gambetti P Ann Neurol; 2010 Aug; 68(2):162-72. PubMed ID: 20695009 [TBL] [Abstract][Full Text] [Related]
36. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. Tagliavini F; Lievens PM; Tranchant C; Warter JM; Mohr M; Giaccone G; Perini F; Rossi G; Salmona M; Piccardo P; Ghetti B; Beavis RC; Bugiani O; Frangione B; Prelli F J Biol Chem; 2001 Feb; 276(8):6009-15. PubMed ID: 11087738 [TBL] [Abstract][Full Text] [Related]
37. An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens. Jones M; Wight D; McLoughlin V; Norrby K; Ironside JW; Connolly JG; Farquhar CF; MacGregor IR; Head MW Brain Pathol; 2009 Apr; 19(2):293-302. PubMed ID: 18507665 [TBL] [Abstract][Full Text] [Related]
39. Glycoform-selective prion formation in sporadic and familial forms of prion disease. Xiao X; Yuan J; Haïk S; Cali I; Zhan Y; Moudjou M; Li B; Laplanche JL; Laude H; Langeveld J; Gambetti P; Kitamoto T; Kong Q; Brandel JP; Cobb BA; Petersen RB; Zou WQ PLoS One; 2013; 8(3):e58786. PubMed ID: 23527023 [TBL] [Abstract][Full Text] [Related]
40. NGS study in a sicilian case series with a genetic diagnosis for Gerstmann-Sträussler-Scheinker syndrome (PRNP, p.P102L). Salemi M; Mandarà LGM; Salluzzo MG; Schillaci FA; Castiglione R; Cordella A; Iorio R; Perrotta CS; Ferri R; Romano C Mol Biol Rep; 2023 Nov; 50(11):9715-9720. PubMed ID: 37812352 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]